Achieving fairer prices for generics and biosimilars

03:54 EST 14 Feb 2020 | Generics and Biosimilars Initiative

Access to safe, effective, quality assured, and affordable essential medicines and vaccines for all has been identified as key to achieving universal health coverage and financial protection. However, this is not always the case, according to Alessandra Ferrario and colleagues from the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, USA [1].

Original Article: Achieving fairer prices for generics and biosimilars


More From BioPortfolio on "Achieving fairer prices for generics and biosimilars"

Quick Search

Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...